Download

Download Full Text (334 KB)

Description

Rocuronium is a paralytic agent commonly used for rapid sequence intubation(RSI): Onset 60-75seconds, duration 40-60minutes; Deep sedation is recommended post RSI; Propofol is a sedative frequently used in ICU for sedation; Barriers to use of propofol for deep sedation post RSI with Rocuronium; Hemodynamic instability; Ordered as PAD light sedation protocol. Baseline Date: Patients intubated using rocuronium in Pod 1, 2, and 4 between January 1st and March 31st 2023; 62 patients received rocuronium; 44 (71%) received rocuronium and propofol; 31 (50%) received propofol with 20 minutes of rocuronium administration; 17 (27.4%) received propofol at appropriate (20mc/kg/min) dose with 20 minutes of rocuronium administration. Note: All patients received Fentanyl.

Publication Date

3-12-2024

Publisher

Henry Ford Health

City

Detroit, Michigan

Keywords

Quality Expo, posters, poster competition

Project #66: Improvement of Deep Sedation Practices Post Rapid Sequence Intubation with Rocuronium

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.